跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 109,488 条关于
“Nova Scotia Fabry Disease Program”
全部
109,488
临床试验
81,671
药物
2,145
机构
317
资讯
25,355
5年前
New Video Resource Highlights Critical Insights from Rare Disease Patient Community
9个月前
Health Canada Approves Elfabrio for Fabry Disease Treatment, Expanding Access to PEGylated Enzyme Replacement Therapy
上个月
Nova Scotia Invests $1.2 Million to Expand Verschuren Centre's Precision Fermentation Biomanufacturing Capacity
去年
Gene Therapy for Fabry Disease Shows Promise with $3.7 Million Cost Savings in Early-Stage Trial
3个月前
Novartis Canada Partners with Nova Scotia Health Innovation Hub to Accelerate Clinical Research and Patient Access to Trials
去年
HLS Therapeutics Secures Nova Scotia Reimbursement for Vascepa, Expanding Cardiovascular Drug Access to 95% of Eligible Canadians
去年
Canada Expands Access to Rare Disease Medications Through Provincial Agreements
11个月前
EMA Rejects Extended Dosing Regimen for Fabry Disease Treatment Elfabrio
去年
Less Frequent Elfabrio Dosing Shows Promise in Fabry Disease
去年
FDA Grants Orphan Drug Designation to EXG110 Gene Therapy for Fabry Disease
第 1 页，共 2536 页
上一页
下一页
